Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.28 USD
+0.08 (6.67%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.24 | -8.33% |
Earnings Summary
For their last quarter, Pacific Biosciences of California (PACB) reported earnings of -$0.26 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PACB's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year increase of 7.69%.
Earnings History
Price & Consensus
Zacks News for PACB
PacBio (PACB) and Form Bio to Boost AAV Industry Development
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services